Ankündigung • Apr 10
Cordlife Group Limited, Annual General Meeting, Apr 27, 2026 Cordlife Group Limited, Annual General Meeting, Apr 27, 2026, at 09:30 Singapore Standard Time. Location: dunearn ballroom iii, raffles town club, 1 plymouth avenue, singapore 297753, Singapore Ankündigung • Jun 26
Medeze Treasury Pte Ltd. completed the acquisition of 0.95% stake in Cordlife Group Limited (SGX:P8A) for SGD 0.61 million. Medeze Treasury Pte Ltd. proposed to acquire an additional 10% stake in Cordlife Group Limited (SGX:P8A) for SGD 6.4 million on May 13, 2025. A cash consideration valued at SGD 0.25 per share will be paid by Medeze Treasury Pte Ltd. As per the transaction, Medeze Treasury Pte Ltd. will acquire 25.6 million shares at SGD 0.25 per share. The transaction is subject to minimum tender and is approved by Securities Industry Council of Singapore. As of May 26, 2025, Relevant Percentage as set out under section 10.2(ii) of the Offer Announcement should be 10.07%, instead of 10.00%. assuming that as at the Record Date there is no change to the total number of Shares (excluding treasury shares), based on 256,307,744 Shares (excluding treasury shares) as at the Record Date: (i) the Relevant Number of Offer Shares to be acquired by the Offeror pursuant to the Partial Offer will be 25,630,774 Shares; and (ii) the Relevant Percentage will be approximately 10.07%. As of May 28, 2025, The Record Date of offer is 5.00 p.m. (Singapore time) on or about June 11, 2025. Despatch of Entitlement Notification Letters is on or about June 16, 2025. Closing Date in respect of the Partial Offer is 5.30 p.m. (Singapore time) on June 25, 2025 or such later date(s) as may be announced from time to time by or on behalf of Offeror. Subject to the Partial Offer becoming unconditional in all respects, settlement of the consideration for the Offer Shares acquired by the Offeror will be made within seven (7) Business Days of the Closing Date.
PrimePartners Corporate Finance Pte. Ltd. served as financial advisor to Medeze Treasury Pte Ltd. Novus Corporate Finance Pte Ltd acted as independent financial adviser to directors of Cordlife Group.
Medeze Treasury Pte Ltd. completed the acquisition of 0.95% stake in Cordlife Group Limited (SGX:P8A) for SGD 0.61 million on June 25, 2025. Ankündigung • May 26
Cordlife Group Limited, Annual General Meeting, Jun 10, 2025 Cordlife Group Limited, Annual General Meeting, Jun 10, 2025, at 09:30 Singapore Standard Time. Location: dunearn ballroom iii, raffles town club, 1 plymouth avenue, singapore 297753, Singapore Ankündigung • Apr 02
Cordlife Group Limited Provides Update on Testing Results for the Additional Low-Risk Tanks Test The Board of Directors of Cordlife Group Limited refers to its announcements dated 8 April 2024 and 25 March 2025 relating to, among others, the Company sending over 200 samples of donated cord blood units ("CBUs") from the five (5) cryogenic storage tanks under investigation by the Ministry of Health which were found to be at low risk of being adversely affected by temperature excursions (" Low-Risk Tanks"), for testing across multiple third-party laboratories ("Additional Low-Risk Tanks Test"). The Board updated that it had received the full results from the Additional Low-Risk Tanks Test ("Additional Low-Risk Tanks Test Results") as of 25 March 2025. The Company is, together with its professional advisers and specialists, in the process of performing a technical analysis on the Additional Low-Risk Tanks Test Results. Ankündigung • Feb 13
Cordlife Group Limited Announces Resignation of CEO Ivan Yiu Pang Fai, Effective February 28, 2025 Cordlife's group chief executive officer Ivan Yiu Pang Fai, 35, has tendered his resignation "to pursue other opportunities" and its board of directors has accepted his decision. His effective date of cessation will be February 28, 2025, Cordlife said in a Feb. 12 bourse filing. The group has commenced the search for a new group CEO and said it would make an "appropriate announcement" when one is appointed. He was appointed as Cordlife's group CEO around a year earlier, on February 19, 2024. The company disclosed then that his brother Yiu Ming Yiu is a non-independent, non-executive director of Cordlife. His father Yiu Chi Shing and his mother Lui Yim Sheung are deemed interested in Cordlife shares held by TransGlobal Real Estate Group, a controlling shareholder of the healthcare group. Mr. Yiu Pang Fai was formerly an executive director of TransGlobal's family office division in Hong Kong prior to his appointment as Cordlife's group CEO. Ankündigung • Jan 08
Cordlife Group Limited Announces Board Changes The Board of Directors of Cordlife Group Limited announced that: Dato' Dr. Teo Tong Kooi has informed the Board that he wished to step down as the Chairman of the Board with immediate effect. The Board records its appreciation for Dato' Dr. Teo's contributions and leadership in his tenure as Chairman. Dato' Dr. Teo will remain on the Board as an Independent Director and retain his respective roles as the Chairman of the Nominating Committee and the Remuneration Committee as well as a member of the Audit and Risk Committee. Mr. Zhai Lingyun has been redesignated from Non-Independent Non-Executive Director to Non-Independent Non-Executive Chairman with immediate effect. Consequent to the abovementioned, the composition of the Board is as follows: Mr. Zhai Lingyun-Chairman, Non-Independent Non-Executive Director; Ms. Chen Xiaoling-Group Executive Director; Mr. Yiu Ming You-Non-Independent Non-Executive Director; Mr. Chow Wai Leong-Non-Independent Non-Executive Director; Dato' Dr. Teo Tong Kooi-Independent Director; Dr. Xu, Tianhong- Independent Director; Mr. Cai, Yong-Independent Director; Mr. Gao Xiang- Independent Director; Dr. Wang Xiaorui-Independent Director; Mr. Sim Sze Kuan-Independent Director. There will be no change to the composition of the Board Committees. Ankündigung • Oct 10
Cordlife Group Limited Announces Change of Joint Company Secretaries Cordlife Group Limited announced that Ms. Cheok Hui Yee has been appointed as the Joint Company Secretary of the Company with effect from 10 October 2024 in place of Ms. Sharon Lim Siew Choo who has resigned as the Joint Company Secretary of the Company with effect from 10 October 2024. Ms. Goh Xun Er, remains as the Company Secretary of the Company. The Board of Directors also wishes to take this opportunity to thank Ms. Sharon for her past services rendered during her tenure as the Joint Company Secretary. Ankündigung • Sep 10
Cordlife Group Limited Announces Cessation of Tan Huiying as Group Director, Quality and Operations, Effective 4 November 2024 Cordlife Group Limited announced the cessation of Tan Huiying as Group Director, Quality and Operations. Role And Responsibilities: As Group Director, Quality and Operations, Ms Tan Huiying is responsible for the Group's operations, information systems and technology, business development activities, and ensuring the Group's quality standards in service and product offerings are maintained according to applicable standards. Reason For Cessation: Ms. Tan Huiying has informed the Company that she has resigned as Group Director, Quality and Operations to pursue her personal interests. Her last day of service will be 4 November 2024. She will relinquish all her appointments within the Group by her last day of service. Her resignation has been accepted by the board of directors of the Company. Ankündigung • Jul 18
Cordlife Group Limited Announces Re-Designation of Chen Xiaoling from Non-Independent Non-Executive Director to Group Executive Director The Board of Directors of Cordlife Group Limited announced the re-designation of Ms. Chen Xiaoling from Non-Independent Non-Executive Director to Group Executive Director with effect from 17 July 2024. As a Group Executive Director, Ms. Chen's immediate role focuses on addressing the critical challenges currently faced by the Company during this pivotal period. Her responsibilities include identifying and prioritizing these challenges, devising strategic solutions, and ensuring timely and effective implementation. This involves closely collaborating with relevant stakeholders to mitigate risks, maintain operational stability, and support the Company's overall objectives amidst the challenges. Her efforts aim to foster resilience and steer the Company towards sustainable growth and success in the face of current difficulties. The Board of Directors comprises Dato' Dr. Teo Tong Kooi as Chairman and Independent Director (ID), Ms. Chen Xiaoling as Group Executive Director (GED), Mr. Zhai Lingyun, Mr. Yiu Ming Yiu, and Mr. Chow Wai Leong as Non-Independent Non-Executive Directors (NINED), and Mr. Cai Yong and Dr. Xu Tianhong as Independent Directors (ID). The Audit and Risk Committee consists of Mr. Cai Yong (Chairman/ID), Mr. Yiu Ming Yiu (Member/NINED), and Dato' Dr. Teo Tong Kooi (Member/ID). The Nominating Committee includes Dato' Dr. Teo Tong Kooi (Chairman/ID), Ms. Chen Xiaoling (Member/GED), Mr. Yiu Ming Yiu (Member/NINED), Mr. Cai Yong (Member/ID), and Dr. Xu Tianhong (Member/ID). The Remuneration Committee is composed of Dato' Dr. Teo Tong Kooi (Chairman/ID), Ms. Chen Xiaoling (Member/GED), Mr. Chow Wai Leong (Member/NINED), Dr. Xu Tianhong (Member/ID), and Mr. Cai Yong (Member/ID). Ankündigung • May 16
Cordlife Group Limited Announces Retirement of Cheong Tuck Yan Titus Jim as Independent Director Cordlife Group Limited announced retirement of Cheong Tuck Yan Titus Jim as Independent director. Role and Responsibilities: Independent Director, Chairman of the Audit and Risk Committee, Member of the Nominating Committee and Remuneration Committee . Job title:Independent Director, Chairman of the Audit and Risk Committee, Member of the Nominating Committee and Remuneration Committee. Other directorships present:Mercy Relief Limited (resignation submitted on 27 March 2024, pending acceptance). Reason cessation: at conclusion of the Annual General Meeting held on 14 May 2024 as Resolution 2 relating to the re-election of Mr. Cheong was not passed by Shareholders at the AGM. Ankündigung • May 11
Cordlife Group Limited Announces Directors Removal Cordlife Group Limited announced removal of Ho Choon Hou, Yeo Hwee Tiong, Cheong Tuck Yan Titus Jim, Joseph Wong Wai Leung and Zhai Lingyun as a Director. Ankündigung • Apr 18
Cordlife Group Limited has filed a Follow-on Equity Offering in the amount of SGD 8.191276 million. Cordlife Group Limited has filed a Follow-on Equity Offering in the amount of SGD 8.191276 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 51,195,478
Price\Range: SGD 0.16
Transaction Features: Subsequent Direct Listing Ankündigung • Feb 29
Cordlife Group Limited Announces Changes in the Composition of the Board and Board Committees The Board of Directors of Cordlife Group Limited announced that Mr. Joseph Wong Wai Leung ("Mr Wong") has stepped down as the Chairman of the Board and the Chairman of the Audit and Risk Committee of the Company with effect from 28 February 2024 due to his personal family and health reasons. Following his resignation as Chairman of the Board and Chairman of the ARC, Dr Ho Choon Hou, the Vice Chairman and Non-Independent and Non-Executive Director of the Company, has been appointed as Acting Chairman of the Board with effect from 29 February 2024 until the appointment of a new Chairman of the Board; and Mr. Cheong Tuck Yan Titus Jim, the Independent Director of the Company, has been appointed as Chairman of the ARC with effect from 29 February 2024. Mr. Wong will remain as an Independent Director of the Company and a Member of the ARC andRemuneration Committee. In Audit and Risk Committee: Mr. Cheong Tuck Yan Titus Jim Chairman /Independent Director, Mr. Joseph Wong Wai Leung Member /Independent Director, Mr. Yeo Hwee Tiong Member /Independent Director, Dr Ho Choon Hou Member /NINED, Mr. Yiu Ming Yiu Member /NINED. In Nominating Committee is Mr. Yeo Hwee Tiong Chairman /Independent Director, Mr. Cheong Tuck Yan Titus Jim Member /Independent Director, Mr. Zhai Lingyun Member /NINED, In Remuneration Committee: Mr. Yeo Hwee Tiong Chairman /Independent Director Mr. Cheong Tuck Yan Titus Jim Member /Independent Director, Mr. Joseph Wong Wai Leung as Member /Independent Director. Ms Chen Xiaoling as Member /NINED, Mr. Chow Wai Leong as Member /NINED. Ankündigung • Jul 01
Cordlife Group Limited Announces Change of Company Secretary The Board of Directors (the "Board") of Cordlife Group Limited announced the appointment of Ms. Low Mei Wan (Ms. Low) as Company Secretary of the company in place of Ms. Ang Siew Koon (Ms. Ang), with effect from 30 June 2023. Ankündigung • May 24
Cordlife Group Limited Announces Resignation of Kuan Yoke Kay as the Joint Company Secretary The board of directors of Cordlife Group Limited announced the resignation of Ms. Kuan Yoke Kay (Ms. Kuan) as the joint company secretary with effect from 23 May 2023. Ms. Ang Siew Koon will remain the sole company secretary. Ankündigung • Jan 17
Cordlife Group Limited Appoints that Hnin Yi as Group Chief Financial Officer Cordlife Group Limited appointed that Hnin Yi as Group Chief Financial Officer. Role And Responsibilities: Executive; Overall management of the Financials of the Group and help the Group achieve its objectives. Working Experience 1. Cordlife Group Limited (Jul 2010 to Jul 2013) - Financial Controller 2. Cordlife Group Limited (Aug 2013 to Jan 2017) - Chief Financial Officer 3. Cordlife Group Limited (Feb 2017 to Oct 2022) - Group Finance Director 4. Cordlife Group Limited (November 2022 to current) - Interim Group Chief Financial Officer. Professional Qualifications 1. Master of Business Administration - University of Manchester 2. Diploma in Accountancy - Ngee Ann Polytechnic. 
